Novartis Investigative Site

Ampelokipoi, GR 115 27

0 studies enrolling now · 3 studies all time

What they study most

Retinopathy of Prematurity, Retinopathy of Prematurity (ROP), Systemic Juvenile Idiopathic Arthritis

Studies at this site

• Rainbow Extension Study — Completed
• An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. — Completed
• RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity — Completed